298 related articles for article (PubMed ID: 30905288)
21. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity.
Seed KD; Lazinski DW; Calderwood SB; Camilli A
Nature; 2013 Feb; 494(7438):489-91. PubMed ID: 23446421
[TBL] [Abstract][Full Text] [Related]
22. CRISPR-Cas immunity leads to a coevolutionary arms race between Streptococcus thermophilus and lytic phage.
Common J; Morley D; Westra ER; van Houte S
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180098. PubMed ID: 30905285
[TBL] [Abstract][Full Text] [Related]
23. Imprecise Spacer Acquisition Generates CRISPR-Cas Immune Diversity through Primed Adaptation.
Jackson SA; Birkholz N; Malone LM; Fineran PC
Cell Host Microbe; 2019 Feb; 25(2):250-260.e4. PubMed ID: 30661951
[TBL] [Abstract][Full Text] [Related]
24. Natural diversity of CRISPR spacers of Thermus: evidence of local spacer acquisition and global spacer exchange.
Lopatina A; Medvedeva S; Artamonova D; Kolesnik M; Sitnik V; Ispolatov Y; Severinov K
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180092. PubMed ID: 30905291
[TBL] [Abstract][Full Text] [Related]
25. Why put up with immunity when there is resistance: an excursion into the population and evolutionary dynamics of restriction-modification and CRISPR-Cas.
Gurney J; Pleška M; Levin BR
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1772):20180096. PubMed ID: 30905282
[TBL] [Abstract][Full Text] [Related]
26. A highly specific phage defense system is a conserved feature of the Vibrio cholerae mobilome.
O'Hara BJ; Barth ZK; McKitterick AC; Seed KD
PLoS Genet; 2017 Jun; 13(6):e1006838. PubMed ID: 28594826
[TBL] [Abstract][Full Text] [Related]
27. Primed CRISPR-Cas Adaptation and Impaired Phage Adsorption in Streptococcus mutans.
Mosterd C; Moineau S
mSphere; 2021 May; 6(3):. PubMed ID: 34011685
[No Abstract] [Full Text] [Related]
28. Interference-driven spacer acquisition is dominant over naive and primed adaptation in a native CRISPR-Cas system.
Staals RH; Jackson SA; Biswas A; Brouns SJ; Brown CM; Fineran PC
Nat Commun; 2016 Oct; 7():12853. PubMed ID: 27694798
[TBL] [Abstract][Full Text] [Related]
29. Spacer acquisition by Type III CRISPR-Cas system during bacteriophage infection of Thermus thermophilus.
Artamonova D; Karneyeva K; Medvedeva S; Klimuk E; Kolesnik M; Yasinskaya A; Samolygo A; Severinov K
Nucleic Acids Res; 2020 Sep; 48(17):9787-9803. PubMed ID: 32821943
[TBL] [Abstract][Full Text] [Related]
30. CRISPR-Cas systems target a diverse collection of invasive mobile genetic elements in human microbiomes.
Zhang Q; Rho M; Tang H; Doak TG; Ye Y
Genome Biol; 2013 Apr; 14(4):R40. PubMed ID: 23628424
[TBL] [Abstract][Full Text] [Related]
31. Analysis of 19 Highly Conserved
Angermeyer A; Das MM; Singh DV; Seed KD
Viruses; 2018 Jun; 10(6):. PubMed ID: 29857590
[TBL] [Abstract][Full Text] [Related]
32. It is unclear how important CRISPR-Cas systems are for protecting natural populations of bacteria against infections by mobile genetic elements.
Westra ER; Levin BR
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):27777-27785. PubMed ID: 33122438
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatic evidence of widespread priming in type I and II CRISPR-Cas systems.
Nicholson TJ; Jackson SA; Croft BI; Staals RHJ; Fineran PC; Brown CM
RNA Biol; 2019 Apr; 16(4):566-576. PubMed ID: 30157725
[TBL] [Abstract][Full Text] [Related]
34. Type III CRISPR-Cas systems can provide redundancy to counteract viral escape from type I systems.
Silas S; Lucas-Elio P; Jackson SA; Aroca-Crevillén A; Hansen LL; Fineran PC; Fire AZ; Sánchez-Amat A
Elife; 2017 Aug; 6():. PubMed ID: 28826484
[TBL] [Abstract][Full Text] [Related]
35. CRISPR-Cas-Mediated Phage Resistance Enhances Horizontal Gene Transfer by Transduction.
Watson BNJ; Staals RHJ; Fineran PC
mBio; 2018 Feb; 9(1):. PubMed ID: 29440578
[TBL] [Abstract][Full Text] [Related]
36. Cas1 and Cas2 From the Type II-C CRISPR-Cas System of
He Y; Wang M; Liu M; Huang L; Liu C; Zhang X; Yi H; Cheng A; Zhu D; Yang Q; Wu Y; Zhao X; Chen S; Jia R; Zhang S; Liu Y; Yu Y; Zhang L
Front Cell Infect Microbiol; 2018; 8():195. PubMed ID: 29951376
[TBL] [Abstract][Full Text] [Related]
37. On the Origin of Reverse Transcriptase-Using CRISPR-Cas Systems and Their Hyperdiverse, Enigmatic Spacer Repertoires.
Silas S; Makarova KS; Shmakov S; Páez-Espino D; Mohr G; Liu Y; Davison M; Roux S; Krishnamurthy SR; Fu BXH; Hansen LL; Wang D; Sullivan MB; Millard A; Clokie MR; Bhaya D; Lambowitz AM; Kyrpides NC; Koonin EV; Fire AZ
mBio; 2017 Jul; 8(4):. PubMed ID: 28698278
[TBL] [Abstract][Full Text] [Related]
38. Broad Targeting Specificity during Bacterial Type III CRISPR-Cas Immunity Constrains Viral Escape.
Pyenson NC; Gayvert K; Varble A; Elemento O; Marraffini LA
Cell Host Microbe; 2017 Sep; 22(3):343-353.e3. PubMed ID: 28826839
[TBL] [Abstract][Full Text] [Related]
39. A Family of Viral Satellites Manipulates Invading Virus Gene Expression and Can Affect Cholera Toxin Mobilization.
Barth ZK; Netter Z; Angermeyer A; Bhardwaj P; Seed KD
mSystems; 2020 Oct; 5(5):. PubMed ID: 33051375
[TBL] [Abstract][Full Text] [Related]
40. Analysis of direct repeats and spacers of CRISPR/Cas systems type I-F in Brazilian clinical strains of Pseudomonas aeruginosa.
Luz ACO; da Silva JMA; Rezende AM; de Barros MPS; Leal-Balbino TC
Mol Genet Genomics; 2019 Oct; 294(5):1095-1105. PubMed ID: 31098740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
